Advanced Solid Malignancies research hub
4 indexed studies · 2 currently recruiting
- recruitingPHASE1, PHASE2
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
This study tests a new drug, AZD9574, alone and with other treatments, for people with advanced cancers. It aims to see how safe it is, how the body handles it, and if it helps shrink tumours.
United States · Australia · Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors
This study is looking into a new medicine called saruparib for adults with advanced cancers. It aims to see how the medicine works in the body and if it's safe. This is an early-stage study to understand more about this potential new treatment.
Bulgaria · Romania - active not recruitingPHASE1, PHASE2
Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies
This study is testing a new drug called CFI-402411, by itself and with another drug called pembrolizumab, for advanced cancers. Doctors want to see if these treatments are safe and if they can help patients whose previous treatments haven't worked.
United States · Canada · Hong Kong - not yet recruitingPHASE1
Human ADME Study of [14C]-AZD1390
This study is looking at a new medicine called AZD1390 for people with advanced cancer. It's a very early-stage trial (Phase 1) to understand how the body handles this medicine: how it's absorbed, moves around, is changed, and leaves the body.
United Kingdom